Upregulation of family with sequence similarity 83 member D expression enhances cell proliferation and motility via activation of Wnt/β-catenin signaling and predicts poor prognosis in gastric cancer

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127(4):679–695. doi:10.1016/j.cell.2006.11.00117110329
   PubMed Web of Science ®Google Scholar
• Chen D, Lin X, Zhang C, et al. Activated Wnt signaling promotes growth and progression of AFP-producing gastric cancer in preclinical models. Cancer Manag Res. 2019;11:1349–1362. doi:10.2147/CMAR.S18721930809100
   PubMed Web of Science ®Google Scholar
• Fang J, Wang H, Fang X, et al. Low STYK1 expression indicates poor prognosis in gastric cancer. Cancer Manag Res. 2018;10:6669–6676. doi:10.2147/CMAR.S18191030584361
   PubMed Web of Science ®Google Scholar
• Koper-Lenkiewicz OM, Kaminska J, Gawronska B, Matowicka-Karna J. The role and diagnostic potential of gastrokine 1 in gastric cancer. Cancer Manag Res. 2019;11:1921–1931. doi:10.2147/CMAR.S19494930881118
   PubMed Web of Science ®Google Scholar
• Strand MS, Lockhart AC, Fields RC. Genetics of gastric cancer. Surg Clin North Am. 2017;97(2):345–370. doi:10.1016/j.suc.2016.11.00928325191
   PubMed Web of Science ®Google Scholar
• Comoglio PM, Giordano S, Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov. 2008;7(6):504–516. doi:10.1038/nrd253018511928
   PubMed Web of Science ®Google Scholar
• Menard S, Pupa SM, Campiglio M, Tagliabue E. Biologic and therapeutic role of HER2 in cancer. Oncogene. 2003;22(42):6570–6578. doi:10.1038/sj.onc.120677914528282
   PubMed Web of Science ®Google Scholar
• Kim MA, Lee HS, Lee HE, Jeon YK, Yang HK, Kim WH. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. Histopathology. 2008;52(6):738–746. doi:10.1111/j.1365-2559.2008.03021.x18397279
   PubMed Web of Science ®Google Scholar
• Jiang X, Wu M, Xu Z, et al. HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer. Cancer Manag Res. 2018;10:6857–6867. doi:10.2147/CMAR.S18836430588091
   PubMed Web of Science ®Google Scholar
• Sun MY, Zhang H, Tao J, Ni ZH, Wu QX, Tang QF. Expression and biological function of rhotekin in gastric cancer through regulating p53 pathway. Cancer Manag Res. 2019;11:1069–1080. doi:10.2147/CMAR.S18534530774435
   PubMed Web of Science ®Google Scholar
• Cipriano R, Miskimen KL, Bryson BL, Foy CR, Bartel CA, Jackson MW. Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer. Mol Cancer Res. 2014;12(8):1156–1165. doi:10.1158/1541-7786.MCR-13-028924736947
   PubMed Web of Science ®Google Scholar
• Cipriano R, Graham J, Miskimen KL, et al. FAM83B mediates EGFR- and RAS-driven oncogenic transformation. J Clin Invest. 2012;122(9):3197–3210. doi:10.1172/JCI6051722886302
   PubMed Web of Science ®Google Scholar
• Cipriano R, Miskimen KL, Bryson BL, Foy CR, Bartel CA, Jackson MW. FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies. Oncotarget. 2013;4(5):729–738. doi:10.18632/oncotarget.102723676467
   PubMedGoogle Scholar
• Lee SY, Meier R, Furuta S, et al. FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice. J Clin Invest. 2012;122(9):3211–3220. doi:10.1172/JCI6049822886303
   PubMed Web of Science ®Google Scholar
• Snijders AM, Lee SY, Hang B, Hao W, Bissell MJ, Mao JH. FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach. Mol Oncol. 2017;11(2):167. doi:10.1002/1878-0261.1201628078827
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu Y, Zhang P, et al. FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7. Oncotarget. 2013;4(12):2476–2486. doi:10.18632/oncotarget.158124344117
   PubMedGoogle Scholar
• Sauer G, Korner R, Hanisch A, Ries A, Nigg EA, Sillje HH. Proteome analysis of the human mitotic spindle. Mol Cell Proteomics. 2005;4(1):35–43. doi:10.1074/mcp.M400158-MCP20015561729
   PubMed Web of Science ®Google Scholar
• Santamaria A, Nagel S, Sillje HH, Nigg EA. The spindle protein CHICA mediates localization of the chromokinesin kid to the mitotic spindle. Curr Biol. 2008;18(10):723–729. doi:10.1016/j.cub.2008.04.04118485706
   PubMed Web of Science ®Google Scholar
• Liao W, Liu W, Liu X, et al. Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma. Oncotarget. 2015;6(27):24132–24147. doi:10.18632/oncotarget.443226125229
   PubMedGoogle Scholar
• Hashimoto M, Kobayashi T, Tashiro H, Arihiro K, Kikuchi A, Ohdan H. h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases. Int J Cancer Manag. 2016;139(4):812–823. doi:10.1002/ijc.30118
   Google Scholar
• Mu Y, Zou H, Chen B, Fan Y, Luo S. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway. Biomed Pharmacother. 2017;90:548–554. doi:10.1016/j.biopha.2017.03.07328407575
   PubMed Web of Science ®Google Scholar
• Perez-Pena J, Alcaraz-Sanabria A, Nieto-Jimenez C, et al. Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors. Oncotarget. 2017;8(13):21733–21740. doi:10.18632/oncotarget.1556228423514
   PubMedGoogle Scholar
• Lin B, Chen T, Zhang Q, et al. FAM83D associates with high tumor recurrence after liver transplantation involving expansion of CD44+ carcinoma stem cells. Oncotarget. 2016;7(47):77495–77507. doi:10.18632/oncotarget.1271527769048
   PubMedGoogle Scholar
• Liao Y, Chen J, Ma J, Mao Q, Wei R, Zheng J. Notch-regulated ankyrin-repeat protein is a novel tissue biomarker that predicts poor prognosis in non-small cell lung cancer. Oncol Lett. 2018;16(2):1885–1891. doi:10.3892/ol.2018.882630008880
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods (San Diego, Calif). 2001;25(4):402–408. doi:10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Olesen I, Thorsen L, Jespersen L. Relative transcription of listeria monocytogenes virulence genes in liver pates with varying NaCl content. Int J Food Microbiol. 2010;141(Suppl 1):S60–S68. doi:10.1016/j.ijfoodmicro.2010.01.04220206397
   PubMedGoogle Scholar
• Zu LD, Peng XC, Zeng Z, et al. Gastrin inhibits gastric cancer progression through activating the ERK-P65-miR23a/27a/24 axis. J Exp Clin Cancer Res. 2018;37(1):115. doi:10.1186/s13046-018-0782-729866191
   PubMed Web of Science ®Google Scholar
• Mungan MU, Gurel D, Canda AE, Tuna B, Yorukoglu K, Kirkali Z. Expression of COX-2 in normal and pyelonephritic kidney, renal intraepithelial neoplasia, and renal cell carcinoma. Eur Urol. 2006;50(1):92–97; discussion 97. doi:10.1016/j.eururo.2005.12.039
   Web of Science ®Google Scholar
• Park JG, Frucht H, LaRocca RV, et al. Characteristics of cell lines established from human gastric carcinoma. Cancer Res. 1990;50(9):2773–2780.2158397
   PubMed Web of Science ®Google Scholar
• Li Y, Ling B, Xiang C-P, Zhang Y, Li -Y-Y, Wu X-L. Characterization of gastric cancer models from different cell lines orthotopically constructed using improved implantation techniques. World J Gastroenterol. 2012;18(2):136–143. doi:10.3748/wjg.v18.i2.13622253519
   PubMed Web of Science ®Google Scholar
• Takahashi N, Okumura T, Motomura W, Fujimoto Y, Kawabata I, Kohgo Y. Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett. 1999;455(1–2):135–139.10428487
   PubMed Web of Science ®Google Scholar
• Ke Y, Ning T, Wang B. [Establishment and characterization of a SV40 transformed human fetal gastric epithelial cell line-GES-1]. Chin J Oncol. 1994;16(1):7.
   Google Scholar
• Barranco SC, Townsend CM, Casartelli C, et al. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res. 1983;43(4):1703–1709.6831414
   PubMed Web of Science ®Google Scholar
• Sekiguchi M, Sakakibara K, Fujii G. Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med. 1978;48(1):61–68.209229
   PubMedGoogle Scholar
• Börner A, Warnken U, Schnölzer M, et al. Subcellular protein extraction from human pancreatic cancer tissues. Biotechniques. 2009;46(4):297–304. doi:10.2144/00011309019450236
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1–6. doi:10.1016/s1476-5586(04)80047-215068665
   PubMed Web of Science ®Google Scholar
• Chen X, Leung SY, Yuen ST, et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell. 2003;14(8):3208–3215. doi:10.1091/mbc.e02-12-083312925757
   PubMed Web of Science ®Google Scholar
• Cho JY, Lim JY, Cheong JH, et al. Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res. 2011;17(7):1850–1857. doi:10.1158/1078-0432.CCR-10-218021447720
   PubMed Web of Science ®Google Scholar
• D’Errico M, de Rinaldis E, Blasi MF, et al. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer. 2009;45(3):461–469. doi:10.1016/j.ejca.2008.10.032
   PubMed Web of Science ®Google Scholar
• Wang Q, Wen YG, Li DP, et al. Upregulated INHBA expression is associated with poor survival in gastric cancer. Med Oncol. 2012;29(1):77–83. doi:10.1007/s12032-010-9766-y21132402
   PubMed Web of Science ®Google Scholar
• Cui J, Chen Y, Chou WC, et al. An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucleic Acids Res. 2011;39(4):1197–1207. doi:10.1093/nar/gkq96020965966
   PubMed Web of Science ®Google Scholar
• Jordan A. OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Comput Sci. 2016;2(2):e67.
   Google Scholar
• Szász AM, Lánczky A, Á N, et al. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget. 2016;7(31):49322–49333. doi:10.18632/oncotarget.1033727384994
   PubMedGoogle Scholar
• Bozatzi P, Dingwell KS, Wu KZ, et al. PAWS1 controls Wnt signalling through association with casein kinase 1alpha. EMBO Rep. 2018;19:4. doi:10.15252/embr.201744807
   Web of Science ®Google Scholar
• Yang M, Huang W, Yang F, Zhang T, Wang C, Song Y. Fam83h mutation inhibits the mineralization in ameloblasts by activating Wnt/beta-catenin signaling pathway. Biochem Biophys Res Commun. 2018;501(1):206–211. doi:10.1016/j.bbrc.2018.04.21629709481
   PubMed Web of Science ®Google Scholar
• Xia MY, Zhao XY, Huang QL, et al. Activation of Wnt/beta-catenin signaling by lithium chloride attenuates d-galactose-induced neurodegeneration in the auditory cortex of a rat model of aging. FEBS Open Bio. 2017;7(6):759–776. doi:10.1002/2211-5463.12220
   PubMed Web of Science ®Google Scholar
• Wang D, Han S, Peng R, et al. FAM83D activates the MEK/ERK signaling pathway and promotes cell proliferation in hepatocellular carcinoma. Biochem Biophys Res Commun. 2015;458(2):313–320. doi:10.1016/j.bbrc.2015.01.10825646692
   PubMed Web of Science ®Google Scholar
• Chiurillo MA. Role of the Wnt/beta-catenin pathway in gastric cancer: an in-depth literature review. World J Exp Med. 2015;5(2):84–102. doi:10.5493/wjem.v5.i2.8425992323
   PubMedGoogle Scholar
• Chen S, Huang J, Liu Z, Liang Q, Zhang N, Jin Y. FAM83A is amplified and promotes cancer stem cell-like traits and chemoresistance in pancreatic cancer. Oncogenesis. 2017;6(3):e300. doi:10.1038/oncsis.2017.328287611
   PubMed Web of Science ®Google Scholar
• Radulescu S, Ridgway RA, Cordero J, et al. Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation. Oncogene. 2013;32(16):2048–2057. doi:10.1038/onc.2012.22422665058
   PubMed Web of Science ®Google Scholar
• Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene. 2006;25(11):1620–1628. doi:10.1038/sj.onc.120937116550162
   PubMed Web of Science ®Google Scholar
• Kishimoto I, Mitomi H, Ohkura Y, Kanazawa H, Fukui N, Watanabe M. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas. J Surg Oncol. 2008;98(1):60–66. doi:10.1002/jso.2108718484097
   PubMed Web of Science ®Google Scholar
• Nie Z, Hu G, Wei G, et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell. 2012;151(1):68–79. doi:10.1016/j.cell.2012.08.03323021216
   PubMed Web of Science ®Google Scholar
• Howard S, Deroo T, Fujita Y, Itasaki N. A positive role of cadherin in Wnt/beta-catenin signalling during epithelial-mesenchymal transition. PLoS One. 2011;6(8):e23899. doi:10.1371/journal.pone.002389921909376
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420–1428. doi:10.1172/JCI3910419487818
   PubMed Web of Science ®Google Scholar
• Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol. 2010;2(2):a002915. doi:10.1101/cshperspect.a00291520182623
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119(6):1429–1437. doi:10.1172/JCI3618319487819
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–890. doi:10.1016/j.cell.2009.11.00719945376
   PubMed Web of Science ®Google Scholar
• Valenta T, Hausmann G, Basler K. The many faces and functions of beta-catenin. Embo J. 2012;31(12):2714–2736. doi:10.1038/emboj.2012.15022617422
   PubMed Web of Science ®Google Scholar
• Liu Y, Huang T, Zhao X, Cheng L. MicroRNAs modulate the Wnt signaling pathway through targeting its inhibitors. Biochem Biophys Res Commun. 2011;408(2):259–264. doi:10.1016/j.bbrc.2011.04.00921501592
   PubMed Web of Science ®Google Scholar
• Ying Y, Tao Q. Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers. Epigenetics. 2009;4(5):307–312. doi:10.4161/epi.4.5.9371
   PubMed Web of Science ®Google Scholar